Blueprint Medicines Corp (NASDAQ:BPMC)

BATS BZX Real-Time Price
As of 1:27pm ET
 -0.26 / -0.48%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Blueprint Medicines Corp have a median target of 93.00, with a high estimate of 152.00 and a low estimate of 40.00. The median estimate represents a +71.81% increase from the last price of 54.13.

Analyst Recommendations

The current consensus among 17 polled investment analysts is to Buy stock in Blueprint Medicines Corp. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.39%
Growthannually 27.87%


Growthquarterly -41.93%
Growthannually 24.12%
Key to the earnings and sales forecast charts.